Literature DB >> 8433569

Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms.

D M Noonan1, J R Hassell.   

Abstract

The complete primary structure of perlecan, the large low-density proteoglycan of basement membranes, has been deduced by cDNA cloning for the mouse and more recently the human gene products. Mouse perlecan contains a 396 kDa core protein with five distinct domains: a heparan sulfate attachment domain, a LDL receptor-like domain, two different laminin-like domains and an N-CAM-like domain. These domains are conserved to a striking degree between mouse and human, including alternate splicing of the N-CAM domain to generate variations of perlecan. These variant sequences also appear to be highly conserved between mouse and human. The strong conservation of these domains, including highly repetitive elements and potential alternative splices, suggest they have vital functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433569     DOI: 10.1038/ki.1993.10

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

1.  Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells.

Authors:  M C Weiser; N A Grieshaber; P E Schwartz; R A Majack
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

2.  Proteome profiling of wild type and lumican-deficient mouse corneas.

Authors:  Hanjuan Shao; Raghothama Chaerkady; Shoujun Chen; Sneha M Pinto; Rakesh Sharma; Bernard Delanghe; David E Birk; Akhilesh Pandey; Shukti Chakravarti
Journal:  J Proteomics       Date:  2011-05-17       Impact factor: 4.044

Review 3.  Extracellular matrix components in intestinal development.

Authors:  P Simon-Assmann; M Kedinger; A De Arcangelis; V Rousseau; P Simo
Journal:  Experientia       Date:  1995-09-29

4.  Perlecan: the multidomain heparan sulphate proteoglycan of basement membrane and extracellular matrix.

Authors:  A D Murdoch; R V Iozzo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Structural characterization of the complete human perlecan gene and its promoter.

Authors:  I R Cohen; S Grässel; A D Murdoch; R V Iozzo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

Review 6.  The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices.

Authors:  R V Iozzo; I R Cohen; S Grässel; A D Murdoch
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

Review 7.  Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.

Authors:  Mary C Farach-Carson; Curtis R Warren; Daniel A Harrington; Daniel D Carson
Journal:  Matrix Biol       Date:  2013-08-31       Impact factor: 11.583

Review 8.  Role of perlecan in skeletal development and diseases.

Authors:  John Hassell; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 9.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

Review 10.  A current view of perlecan in physiology and pathology: A mosaic of functions.

Authors:  Maria A Gubbiotti; Thomas Neill; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.